ClinicalSeriesLive

Continuing Education

Biosimilars - ARCHIVED CME


Presentations

  • NON
    CME

    Biosimilars 101: Definitions and Distinctions

    Speakers:Jonathan Kay, MD, Professor of Medicine
    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP, Clinical Pharmacist

    Duration: 60 minutes

    Presented on: February 1, 2016

    *This session is not eligible for AMA PRA Category 1 CreditsTM

  • NON
    CME

    Clinical Applications and Concerns Regarding Biosimilar Products

    Speakers:Jonathan Kay, MD, Professor of Medicine
    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP, Clinical Pharmacist
    Andrew Evens, DO, MSc, Professor of Medicine

    Duration: 60 minutes

    Presented on: February 1, 2016

    *This session is not eligible for AMA PRA Category 1 CreditsTM


Speakers

  • Jonathan Kay, MD

    Jonathan Kay, MD

    Jonathan Kay, MD

    Professor of Medicine

    Jonathan Kay, MD, received his medical degree from the University of California School of Medicine in San Francisco, California. He then completed an internship and residency at the Hospital of the University of Pennsylvania in Philadelphia and fellowships in rheumatology and immunology at The Brigham and Women’s Hospital and Harvard Medical School in Boston, Massachusetts. Dr. Kay is Professor of Medicine at the University of Massachusetts Medical School and a Physician at UMass Memorial Medical Center in Worcester, where he directs Clinical Research in the Division of Rheumatology. Dr. Kay lectures internationally and is the author of more than 120 publications and book chapters.
  • Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Clinical Pharmacist

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Andrew Evens, DO, MSc

    Andrew Evens, DO, MSc

    Andrew Evens, DO, MSc

    Professor of Medicine

    Dr. Evens is Professor of Medicine at Tufts University School of Medicine and he is Chief of the Division of Hematology/Oncology and Director of the Tufts Cancer Center at Tufts Medical Center in Boston, Massachusetts. He was also named the Chan Soon-Shiong Endowed Scholar in Precision Medicine at Tufts Medical Center. Dr. Evens completed his Hematology/Oncology fellowship at Northwestern University Feinberg School of Medicine and The Robert H. Lurie Comprehensive Cancer Center (RHLCCC). As a physician-scientist, Dr. Evens’ focus is in the biology, prognosis, and treatment of Non-Hodgkin lymphoma and Hodgkin disease/lymphoma. He has designed and conducted a multitude of clinical trials in lymphoid malignancies and he has authored or co-authored more than 150 original articles in this field.